Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-1-21
pubmed:databankReference
pubmed:abstractText
Diastolic dysfunction may precede development of heart failure in hypertensive patients. We randomized 228 patients with uncontrolled hypertension, preserved ejection fraction, and diastolic dysfunction to 2 targeted treatment strategies: intensive, with a systolic blood pressure target of <130 mm Hg, or standard, with a systolic blood pressure target of <140 mm Hg, using a combination of valsartan, either 160 or 320 mg, plus amlodipine, either 5 or 10 mg, with other antihypertensive medications as needed. Echocardiographic assessment of diastolic function was performed at baseline and after 24 weeks in a prospective, open-label, blinded end point design. Blood pressure was reduced significantly in both groups, from 161.2+/-13.9/90.1+/-12.0 to 130.8+/-12.3/74.9+/-9.1 mm Hg (P<0.0001) in the intensive arm and from 162.1+/-13.2/93.7+/-12.2 to 137.0+/-12.9/79.6+/-11.0 mm Hg (P<0.0001) in the standard arm (P<0.003 for between-group comparisons). Myocardial relaxation velocity improved from 7.6+/-1.1 to 9.2+/-1.7 cm/s (Delta 1.54+/-1.4 cm/s; P<0.0001) in the intensive arm and from 7.5+/-1.3 to 9.0+/-1.9 cm/s (Delta 1.48+/-1.6 cm/s; P<0.0001) in the standard arm, with no difference between the 2 strategies in the achieved improvement (P=0.58). The degree of improvement in annular relaxation velocity was associated with the extent of systolic blood pressure reduction, and patients with the lowest achieved systolic blood pressure had the highest final diastolic relaxation velocities.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1524-4563
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-8
pubmed:meshHeading
pubmed-meshheading:19996069-Age Factors, pubmed-meshheading:19996069-Aged, pubmed-meshheading:19996069-Antihypertensive Agents, pubmed-meshheading:19996069-Blood Pressure Determination, pubmed-meshheading:19996069-Dose-Response Relationship, Drug, pubmed-meshheading:19996069-Drug Administration Schedule, pubmed-meshheading:19996069-Drug Therapy, Combination, pubmed-meshheading:19996069-Echocardiography, Doppler, pubmed-meshheading:19996069-Female, pubmed-meshheading:19996069-Follow-Up Studies, pubmed-meshheading:19996069-Heart Failure, Diastolic, pubmed-meshheading:19996069-Humans, pubmed-meshheading:19996069-Hypertension, pubmed-meshheading:19996069-Hypertrophy, Left Ventricular, pubmed-meshheading:19996069-Linear Models, pubmed-meshheading:19996069-Male, pubmed-meshheading:19996069-Middle Aged, pubmed-meshheading:19996069-Multivariate Analysis, pubmed-meshheading:19996069-Probability, pubmed-meshheading:19996069-Risk Assessment, pubmed-meshheading:19996069-Severity of Illness Index, pubmed-meshheading:19996069-Sex Factors, pubmed-meshheading:19996069-Statistics, Nonparametric, pubmed-meshheading:19996069-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction.
pubmed:affiliation
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. Ssolomon@rics.bwh.harvard.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't